Duchassaing D, Dingeon B, Chalas J, Coude M, Coulhon M P, Launay J M
Service de biochimie, CH Victor-Dupouy, 95107 Argenteuil cedex, France.
Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):617-21.
Medical prescriptions for molecular genetic analyses are not yet very common in general practice, neverless they are becoming more and more frequent, and therefore it is more difficult to deal with them in part because of the recent french rules. Laboratory managers are supposed to be able to deal with such requests. This document, describing good laboratory practices, has been elaborated by members of the group "molecular genetics" from the "College National de Biochimie des Hôpitaux", providing details about: assessment of the prescriptions, including patient's consent, choice of the executing laboratory, specimen transmission, assessment and control of clinical and biological data, results transmission, confidentiality, archiving system. Such recommendations should facilitate exchanges with specialized laboratories, being specifically approved for practicing such analyses. The authors draw the attention of laboratory managers to the specificities of such requests.
在一般医疗实践中，用于分子遗传学分析的医学处方尚不常见，但它们正变得越来越频繁，因此处理起来更加困难，部分原因是由于最近的法国法规。实验室管理人员应该能够处理此类请求。本文件描述了良好实验室规范，由“国立医院生物化学学院”的“分子遗传学”小组的成员制定，详细介绍了：处方评估，包括患者同意书、执行实验室的选择、样本传输、临床和生物学数据的评估与控制、结果传输、保密性、存档系统。此类建议应有助于与专门从事此类分析的专业实验室进行交流。作者提请实验室管理人员注意此类请求的特殊性。
